Meeder Asset Management Inc Alnylam Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

  • $1.58 Billion
  • Q1 2024

A detailed history of Meeder Asset Management Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 24 shares of ALNY stock, worth $5,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Holding current value
$5,832
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$146.51 - $198.2 $3,516 - $4,756
24 New
24 $3,000
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $1,108 - $1,856
8 Added 16.67%
56 $11,000
Q2 2022

Aug 08, 2022
SELL
$120.42 - $169.29 $1,806 - $2,539
-15 Reduced 23.81%
48 $7,000
Q1 2022

May 10, 2022
BUY
$127.18 - $173.91 $8,012 - $10,956
63 New
63 $10,000
Q4 2021

Feb 11, 2022
SELL
$159.56 - $209.29 $814,394 - $1.07 Million
-5,104 Closed
0 $0
Q3 2021

Nov 08, 2021
BUY
$169.75 - $207.73 $855,030 - $1.05 Million
5,037 Added 7517.91%
5,104 $964,000
Q2 2021

Aug 09, 2021
SELL
$128.63 - $176.89 $128 - $176
-1 Reduced 1.47%
67 $11,000
Q1 2021

Apr 28, 2021
SELL
$126.83 - $175.69 $1,902 - $2,635
-15 Reduced 18.07%
68 $10,000
Q4 2020

Feb 09, 2021
SELL
$122.97 - $147.0 $599,847 - $717,066
-4,878 Reduced 98.33%
83 $11,000
Q3 2020

Nov 02, 2020
SELL
$121.19 - $165.49 $65,927 - $90,026
-544 Reduced 9.88%
4,961 $722,000
Q2 2020

Aug 11, 2020
SELL
$104.21 - $156.44 $160,274 - $240,604
-1,538 Reduced 21.84%
5,505 $816,000
Q1 2020

May 15, 2020
SELL
$93.12 - $133.99 $683,687 - $983,754
-7,342 Reduced 51.04%
7,043 $766,000
Q4 2019

Feb 13, 2020
BUY
$74.51 - $124.23 $983,681 - $1.64 Million
13,202 Added 1115.98%
14,385 $1.66 Million
Q3 2019

Oct 17, 2019
SELL
$70.9 - $87.82 $11,344 - $14,051
-160 Reduced 11.91%
1,183 $95,000
Q2 2019

Aug 05, 2019
BUY
$65.86 - $92.79 $65,925 - $92,882
1,001 Added 292.69%
1,343 $97,000
Q1 2019

Apr 16, 2019
BUY
$72.76 - $93.45 $19,135 - $24,577
263 Added 332.91%
342 $32,000
Q4 2018

Jan 17, 2019
BUY
$62.67 - $88.33 $4,950 - $6,978
79 New
79 $6,000
Q3 2018

Nov 02, 2018
SELL
$87.52 - $122.67 $21,792 - $30,544
-249 Closed
0 $0
Q2 2018

Jul 24, 2018
SELL
$88.31 - $107.8 $49,630 - $60,583
-562 Reduced 69.3%
249 $0
Q1 2018

May 03, 2018
SELL
$115.92 - $148.54 $186,399 - $238,852
-1,608 Reduced 66.47%
811 $97,000
Q4 2017

Feb 02, 2018
BUY
$114.49 - $139.98 $229,323 - $280,379
2,003 Added 481.49%
2,419 $307,000
Q3 2017

Oct 20, 2017
BUY
$72.53 - $118.27 $30,172 - $49,200
416
416 $49,000

Others Institutions Holding ALNY

# of Institutions
584
Shares Held
104M
Call Options Held
2.82M
Put Options Held
1.75M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email